Lupin launches generic Celebrex caps

MUMBAI, India and BALTIMORE — Lupin Pharmaceuticals launched the authorized generic version of Celebrex capsules in 50-, 100-, 200- and 400-mg dosage strengths. 

 

Celebrex, which is marketed by Pfizer, had annual sales in the United States of $2.54 as of September 2014, according to IMS data.